| P2093 | author name string | Raymond Vanholder | |
| | Wim Van Biesen | |
| | Roberto Pecoits-Filho | |
| | Anneleen Pletinck | |
| | Eva Schepers | |
| | Griet Glorieux | |
| | Annemieke Dhondt | |
| | Filip De Somer | |
| | Andréa Moreno-Amaral | |
| | Natalia Borges Bonan | |
| P2860 | cites work | K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 |
| | Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior | Q29616447 |
| | In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion | Q32063718 |
| | Effect of different dialysis modalities on microinflammatory status and endothelial damage. | Q33684098 |
| | The removal of uremic toxins. | Q33998529 |
| | Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes | Q34055659 |
| | Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications | Q34100425 |
| | The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review | Q34103477 |
| | Nomenclature of monocytes and dendritic cells in blood. | Q34125860 |
| | Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease | Q35985806 |
| | Chronic kidney disease as cause of cardiovascular morbidity and mortality | Q36091038 |
| | DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation | Q36957027 |
| | Microinflammation and endothelial damage in hemodialysis. | Q37152601 |
| | Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases | Q37307308 |
| | Platelets and the immune continuum | Q37857647 |
| | Monocyte subpopulations and cardiovascular risk in chronic kidney disease | Q37992796 |
| | Normal and pathologic concentrations of uremic toxins | Q38012908 |
| | Monocyte heterogeneity in human cardiovascular disease. | Q38035114 |
| | Clinical management of the uraemic syndrome in chronic kidney disease | Q38382365 |
| | SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset | Q38487146 |
| | Monocyte inflammatory profile is specific for individuals and associated with altered blood lipid levels | Q38750726 |
| | Oxidized LDL-activated platelets induce vascular inflammation | Q43087807 |
| | Platelet-induced expression of FcγRIII (CD16) on human monocytes | Q44649992 |
| | Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients | Q46295199 |
| | Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia. | Q46599949 |
| | Pro-inflammatory cytokines and leukocyte oxidative burst in chronic kidney disease: culprits or innocent bystanders? | Q49161489 |
| | P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production | Q49168516 |
| | Shift of monocyte subsets along their continuum predicts cardiovascular outcomes. | Q50089651 |
| | Chronic Kidney Disease. | Q51043966 |
| | The continuum of monocyte phenotypes: Experimental evidence and prognostic utility in assessing cardiovascular risk. | Q52722760 |
| | Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation. | Q54395539 |
| | The role of platelets in inflammation. | Q54784519 |
| | Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). | Q55476982 |
| | Lower Apo A-I and Lower HDL-C Levels Are Associated With Higher Intermediate CD14 ++ CD16 + Monocyte Counts That Predict Cardiovascular Events in Chronic Kidney Disease | Q57132129 |
| | Chronic Kidney Disease Severity Is Associated With Selective Expansion of a Distinctive Intermediate Monocyte Subpopulation | Q60912551 |
| | Platelets in atherosclerosis | Q63916904 |
| | Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis | Q70863401 |
| | The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population | Q82065955 |
| | Microinflammation in hemodialysis patients is associated with increased CD14CD16(+) pro-inflammatory monocytes: possible modification by on-line hemodiafiltration | Q83224585 |
| | Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production | Q83741212 |
| | CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease | Q85189304 |
| | Monocyte profile in peripheral blood of gestational diabetes mellitus patients | Q89639217 |
| | Sudan-β-d-glucuronides and their use for the histochemical localization of β-glucuronidase activity in transgenic plants | Q91514060 |
| P433 | issue | 1 | |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 10236 | |
| P577 | publication date | 2019-07-15 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease | |
| P478 | volume | 9 | |